Therapeutics is a small, family-owned medical practice whose mission is to help patients experience the natural relief that cannabis provides. Because there is such a lack of information on cannabis, Medical Marijuana Therapeutics was established to help patients access the medicine they need. Their website contains many helpful resources, including patient testimonials. To learn more, read on! And stay tuned for the next installment! Read on to discover more about the practice.The committee reviewed the evidence regarding the potential medicinal value of cannabis and cannabinoids for a range of health conditions.
They reviewed the evidence for their effectiveness in the treatment of cancer, obesity, wasting disease, epilepsy, addiction, schizophrenia, and Tourette's syndrome. The committee also reviewed marijuana's potential to treat various autoimmune disorders. The committee noted that many cancer patients reported better quality of life with use CANNABIS PRODUCTS compared with their treatment regimens, including more energy and fewer side effects.
Two small studies involving people with ALS did not show significant differences in outcomes between the two groups. The sample size was small and the duration was short, so the study outcomes may not have been statistically significant. The dose was also too low to determine activity. The researchers also found that cannabis did not significantly improve the quality of life for patients with ALS compared to their controls. But the results are still preliminary and may be overly optimistic.
Studies involving oral cannabinoid preparations, including THC, CBD, have shown minimal benefits compared to placebo. However, a seven-patient trial of the cannabis compound nabilone showed an improvement in dyskinesia associated with levodopa therapy. Unfortunately, the small sample size makes interpretation of the results impossible. Nonetheless, these trials provide a promising starting point for marijuana therapeutics.
The FDA has approved this two marijuana-derived drugs containing CBD and THC. These drugs treat nausea caused by chemotherapy and improve appetite in AIDS patients. A fourth study, by Whiting et al., evaluated a cannabis-based formulation of the drug dronabinol. The study also included a cannabis-derived agonist, megestrol acetate. It is difficult to evaluate the efficacy of cannabis-based medications without adequate clinical trials.
Cannabis has also been used by cancer patients to manage their cancer pain and nausea during chemotherapy. Studies in animals show that the chemical components of marijuana, called cannabinoids, can help kill cancer cells. Also marijuana can be an effective treatment for cancer.
Currently, there is no conclusive evidence of the effectiveness of cannabis in treating depressive disorder. However, a good-quality review of cannabis found no RCT specifically investigating its efficacy in this condition. Overall, five RCTs enrolled 634 participants with depressive symptoms, chronic pain, multiple sclerosis with spasticity, or other conditions. Various marijuana treatments, including dronabinol, were compared to placebo. The results of the trials were reported up to nine weeks following randomization.